Open: 1:30 PM
CohBar Stock Price Graph
CohBar Stock Price Today
CohBar, Inc. (CWBR) stock rallied over 3.90% intraday to trade at $0.8 a share on NASDAQ. The stock opened with a gain of 193.51% at $2.26 and touched an intraday high of $2.36, rising 3.90% against the last close of $0.77. The CohBar, Inc. in stock market went to a low of $2.26 during the session.
CohBar Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
CohBar Stock Price History Chart
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute respiratory distress syndrome, cancer, and cardiovascular diseases, such as Alzheimer's disease. Its lead clinical candidate is CB4211, a novel refined analog of the MOTS-c mitochondrial derived peptide, which is in Phase Ib stage of a Phase Ia/Ib clinical trial for the treatment of NASH and obesity. The company's preclinical programs include CB5138 analogs for fibrotic diseases; and CB5064 analogs for COVID-19 associated ARDS. CohBar, Inc. was incorporated in 2007 and is headquartered in Menlo Park, California.
Frequently Asked Questions
What is the current CohBar, Inc. (CWBR) stock price?
CohBar, Inc. (NASDAQ: CWBR) stock price is $0.80 in the last trading session. During the trading session, CWBR stock reached the peak price of $2.36 while $2.26 was the lowest point it dropped to. The percentage change in CWBR stock occurred in the recent session was 3.90% while the dollar amount for the price change in CWBR stock was $0.03.
CWBR's industry and sector of operation?
The NASDAQ listed CWBR is part of Biotechnology industry that operates in the broader Healthcare sector. CohBar, Inc. , a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases.
Who are the executives of CWBR?
Prof. John M. Amatruda M.D., Ph.D.
Co-Founder & Member of Scientific Advisory Board
Dr. Joseph J. Sarret J.D., M.D.
Chief Executive Officer & Director
Dr. Kent Grindstaff Ph.D.
Senior Vice President of Research
Mr. Jeffrey F. Biunno C.P.A., M.B.A.
Chief Financial Officer, Treasurer & Sec.
How CWBR did perform over past 52-week?
CWBR's closing price is 0.20% higher than its 52-week low of $1.43 where as its distance from 52-week high of $6.9 is -0.77%.
How many employees does CWBR have?
Number of CWBR employees currently stands at N/A. CWBR operates from 1455 Adams Drive, Menlo Park, CA 94025, US.
Link for CWBR official website?
Official Website of CWBR is: https://www.cohbar.com
How do I contact CWBR?
How many shares of CWBR are traded daily?
CWBR stock volume for the day was 3509.00 shares. The average number of CWBR shares traded daily for last 3 months was 42.3 Thousands.
What is the market cap of CWBR currently?
The market value of CWBR currently stands at $2.18 Million with its latest stock price at $0.80 and N/A of its shares outstanding.